ARTES - Vaccines
ARTES offers a range of vaccine producing cell lines and processes for out-licensing and technology transfer. All listed cell lines are based on our safe and high yield yeast expression system Hansenula polymorpha.
-
Most popular related searches
Details
- Avian Flu : pre-clinical PoC; based on METAVAX® VLP platform highly immunogenic, adjuvant-free; cell line and process available
- Hepatitis B : licensed worldwide; new technology with improved yield; RCB, USP, DSP IPC/QC protocols available
- HPV (L1-6; -11; -16; -18) : RCB, USP, DSP IPC/QC protocols for the different serotypes available
Customer reviews
No reviews were found for ARTES - Vaccines. Be the first to review!